| Description |
xx, 556 pages : illustrations ; 26 cm |
| Contents |
Contents note continued: 18.Emerging Role of Radiotherapy in the Management of Liver Metastases / Laura A. Dawson -- 19.Chemoembolization for Primary and Metastatic Liver Cancer / Jean-Francois H. Geschwind -- 20.Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic Malignancies / Riad Salem -- pt. 3 CHEMOTHERAPY FOR COLORECTAL CANCER -- 21.Introduction to Chemotherapy for Colorectal Cancer / Edward Chu -- 22.Biology of Colorectal Cancer / Edward Chu -- 23.Stage II and Stage III Colon Cancer: Treatment Advances and Future Directions / Aimery De Gramont -- 24.Gene Profiling in Early Stage Disease / David J. Kerr -- 25.Optimal Delivery of Cytotoxic Chemotherapy for Colon Cancer / Richard M. Goldberg -- 26.Integration of Anti-Vascular Endothelial Growth Factor Therapies with Cytotoxic Chemotherapy in the Treatment of Colorectal Cancer / Paulo M. Hoff -- |
|
Contents note continued: 27.Integration of Anti-Epidermal Growth Factor Receptor Therapies with Cytotoxic Chemotherapy / Josep Tabernero -- 28.Treatment of Liver-Limited Metastatic Colorectal Cancer / Steven R. Alberts -- 29.Chemotherapy for the Elderly Patient with Colorectal Cancer / Stuart M. Lichtman -- 30.Combined Modality Therapy for Rectal Cancer / Vincenzo Valentini -- 31.Molecular Markers in the Treatment of Metastatic Colorectal Cancer / Heinz-Josef Lenz -- 32.Novel Agents in the Treatment of Metastatic Colorectal Cancer / S. Gail Eckhardt -- pt. 4 IMMUNOTHERAPY OF CANCER -- 33.Introduction for Immunotherapy of Cancer / Jeffrey S. Weber -- 34.Chemoimmunotherapy / Leisha A. Emens -- 35.Cellular Vaccine Approaches / Elizabeth M. Jaffee -- 36.Immune Regulatory Antibodies: Are They the Next Advance? / Jeffrey S. Weber -- 37.Dendritic Cells: Are They Clinically Relevant? / Jacques Banchereau -- |
|
Contents note continued: 38.Chemokines: Can Effector Cells Be Redirected to the Site of the Tumor? / James J. Mule -- 39.Adoptive Cell Therapy: Genetic Modification to Redirect Effector Cell Specificity / Steven A. Rosenberg -- 40.Regulatory T Cells: Overcoming Suppression of T-Cell Immunity / Robert H. Vonderheide -- 41.Myeloid-Derived Suppressor Cells in Human Cancer / Dmitry I. Gabrilovich -- 42.Indoleamine 2,3-Dioxygenase: Is It an Immune Suppressor? / Scott Antonia -- 43.Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma / Craig L. Slingluff, Jr. -- 44.Adoptive Therapy Using Antigen-Specific T-Cell Clones / Cassian Yee -- 45.Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy / Stanley R. Riddell -- 46.Toll-Like Receptor Agonists: Are They Good Adjuvants? / Nina Bhardwaj -- 47.Novel Gamma-Chain Cytokines as Candidate Immune Modulators in Immune Therapies for Cancer / Crystal L. Mackall -- |
|
Contents note continued: 48.Gene Signature in Melanoma Associated with Clinical Activity: A Potential Clue to Unlock Cancer Immunotherapy / Vincent G. Brichard -- pt. 5 THE ROLE OF THE ONCOLOGIST IN PALLIATIVE CARE -- 49.The Role of the Oncologist in Palliative Care / Nathan Cherny -- 50.The Oncologist's Role in Delivering Palliative Care / Nathan Cherny -- 51.What Is the Evidence That Palliative Care Teams Improve Outcomes for Cancer Patients and Their Families? / Catherine J. Evans -- 52.Standards for Palliative Care Delivery in Oncology Settings / Amy P. Abernethy -- 53.Utility and Use of Palliative Care Screening Tools in Routine Oncology Practice / David C. Currow -- 54.Discussing Prognosis: Balancing Hope and Realism / Robert M. Arnold -- 55.Palliative Chemotherapy: When Is It Worth It and When Is It Not? / Thomas J. Smith -- 56.Palliative Radiotherapy: When Is It Worth It and When Is It Not? / Benjamin Corn -- |
|
Contents note continued: 57.Invasive Palliative Interventions: When Are They Worth It and When Are They Not?... / Daniel Bueche -- 58.Working with a Palliative Care Team / Jamie H. Von Roenn -- 59.The Oncologist's Role in Managing Depression, Anxiety, and Demoralization with Advanced Cancer / Salomon Stemmer -- 60.Evidence-Based Approaches to Pain in Advanced Cancer / Sydney Morss Dy -- 61.Evidence-Based Approaches to Other Symptoms in Advanced Cancer / Colleen C. Apostol -- 62.Emergencies in Palliative Care / Frank Van Fraeyenhove -- 63.Communication Skills for Discussing Treatment Options When Chemotherapy Has Failed / James A. Tulsky -- 64.Maintaining the Will to Live of Patients with Advanced Cancer / Gary Rodin -- 65.The Oncologist's Role in Care of the Dying Cancer Patient / Christine Sanderson -- pt. 6 IMPACT OF HEALTH CARE REFORM ON CANCER PATIENTS -- 66.Health Care Reform 2010: Expected Favorable Impact on Childhood Cancer Patients and Survivors / Gregory H. Reaman -- |
|
Contents note continued: 67.Potential Favorable Impact of the Affordable Care Act of 2010 on Cancer in Young Adults in the United States / W. Archie Bleyer -- 68.The Patient Protection and Affordable Care Act: How Will It Affect Private Health Insurance for Cancer Patients? / Gary Claxton -- 69.Impact of Health Care Reform Legislation on Uninsured and Medicaid-Insured Cancer Patients / Elizabeth M. Ward -- 70.Impact of Health Care Reform on Medicare and Dual Medicare--Medicaid Beneficiaries / Meredith Philyaw -- 71.The Patient Protection and Affordable Care Act: Exploring the Potential Impact on Oncology Practice / Shelagh E. Foster -- 72.An Opportunity for Coordinated Cancer Care: The Intersection of Health Care Reform, Primary Care Providers, and Cancer Patients / Marc Altshuler -- 73.Impact of Healthcare Reform on the Cancer Patient: A View from Cancer Executives / William J. Laffey -- |
|
Contents note continued: 74.The Anticipated and Unintended Consequences of PPACA on Cancer Research / David C. Hohn -- 75.The Association of Insurance and Stage at Diagnosis Among Patients Aged 55 to 74 Years in the National Cancer Database / Katherine Virgo -- 76.ObamaCare: Miscalculated Assurances / Roger M. Battistella -- 77.Concerns Presented by the New Health Legislation / Stuart M. Butler |
|
Contents note continued: pt. 2 LOCAL THERAPIES IN THE TREATMENT OF LIVER METASTASES -- 10.Introduction to Local Therapies in the Treatment of Liver Cancer / Alfred E. Chang -- 11.Hepatic Imaging for Metastatic Disease / Isaac R. Francis -- 12.Surgical Treatment of Hepatic Colorectal Metastasis: Evolving Role in the Setting of Improving Systemic Therapies and Ablative Treatments in the 21st Century / Yuman Fong -- 13.Thermal Ablative Therapies for Secondary Hepatic Malignancies / Timothy M. Pawlik -- 14.Focused Ultrasound as a Local Therapy for Liver Cancer / Ferenc A. Jolesz -- 15.The Role of Chemotherapy in Managing Patients with Resectable Liver Metastases / Axel Grothey -- 16.Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients with Isolated and Unresectable Liver Metastases / Caroline C. Butler -- 17.Implanted Hepatic Arterial Infusion Pumps / Nancy E. Kemeny -- |
|
Machine generated contents note: pt. 1 TRIPLE-NEGATIVE BREAST CANCER -- 1.Triple-Negative Breast Cancer: From Epidemiology to Treatment / Clifford A. Hudis -- 2.What is the Difference between Triple-Negative and Basal Breast Cancrs? / Stephen K. Chia -- 3.Triple-Negative Breast Cancers: A View from 10,000 Feet / Blase N. Polite -- 4.Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer: Promising Clinical Target or Only a Marker? / Olufunmilayo I. Olopade -- 5.Triple-Negative Breast Cancer: Role of Antiangiogenic Agents / Hope S. Rugo -- 6.BRCA Gene Structure and Function in Tumor Suppression: A Repair-Centric Perspective / Mary Ellen Moynahan -- 7.Poly (ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer / Mark Robson -- 8.Triple-Negative Breast Cancer: Role of Specific Chemotherapy Agents / Steven J. Isakoff -- 9.Triple-Negative Breast Cancer: Role of the Androgen Receptor / Tiffany A. Traina -- |
| Subject |
Medical Oncology.
|
|
Neoplasms.
|
| Author |
DeVita, Vincent T., Jr., 1935-
|
|
Lawrence, Theodore S.
|
|
Rosenberg, Steven A.
|
| ISBN |
1451142692 |
|
9781451142693 |
|
